Addex Therapeutics Ltd (ADXN) — Cash Flow Quality Index
Addex Therapeutics Ltd (ADXN) has a Cash Flow Quality Index of -0.21x as of June 2024. Operating cash flow of $-2.76 Million is below net income of $12.88 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore Addex Therapeutics Ltd cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Addex Therapeutics Ltd Cash Flow Quality Index (2024–2024)
Historical Cash Flow Quality Index for Addex Therapeutics Ltd across 1 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see ADXN operating cash flow.
Annual Cash Flow Quality Index for Addex Therapeutics Ltd (2024–2024)
Year-by-year earnings quality comparison for Addex Therapeutics Ltd.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | -0.76x | $-5.37 Million | $7.06 Million | — |